Get the latest Science News and Discoveries

Popular weight-loss drugs Ozempic and Wegovy may slow biological aging


Researchers found that semaglutide, the active ingredient in Ozempic and Wegovy, slowed biological aging markers in adults with HIV, marking the first clinical evidence that the drug may influence human aging. Although the findings are encouraging, scientists say larger studies are needed before concluding that the medication can help people age more slowly.

None

Get the Android app

Or read this on ScienceDaily

Read more on:

Photo of Wegovy

Wegovy

Photo of Ozempic

Ozempic

Photo of biological aging

biological aging

Related news:

News photo

IU study finds obesity 'fuels' leukemia, but a combo using popular weight-loss drugs may stop it - EurekAlert!

News photo

The Ozempic and Wegovy mistake sending thousands to poison control

News photo

The Future of Obesity Care Goes Far Beyond Ozempic, Wegovy, and Zepbound